These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Coronary calcium density in relation to coronary heart disease and cardiovascular disease in adults with diabetes or metabolic syndrome: the Multi-ethnic Study of Atherosclerosis (MESA). Zhao Y; Malik S; Criqui MH; Allison MA; Budoff MJ; Sandfort V; Wong ND BMC Cardiovasc Disord; 2022 Dec; 22(1):536. PubMed ID: 36494811 [TBL] [Abstract][Full Text] [Related]
44. Hidradenitis suppurativa and the metabolic syndrome. Ergun T Clin Dermatol; 2018; 36(1):41-47. PubMed ID: 29241751 [TBL] [Abstract][Full Text] [Related]
45. The Treatment of Obesity in Cardiac Rehabilitation: A REVIEW AND PRACTICAL RECOMMENDATIONS. Ades PA; Savage PD J Cardiopulm Rehabil Prev; 2021 Sep; 41(5):295-301. PubMed ID: 34461619 [TBL] [Abstract][Full Text] [Related]
46. Preventing cardiovascular disease and diabetes: a call to action from the ADA and AHA. Wyne KL J Cardiometab Syndr; 2006; 1(3):220-1. PubMed ID: 17679801 [No Abstract] [Full Text] [Related]
47. Five year study of cardiovascular risk factors in Japanese people: implications concerning new onset of metabolic syndrome. Suzuki A; Kosuge K; Nanyu O; Watanabe H; Watanabe T; Usuda Y; Sasaki S; Aizawa Y Intern Med; 2010; 49(1):1-6. PubMed ID: 20045994 [TBL] [Abstract][Full Text] [Related]
48. Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases. Nguyen TTB; Jin YY; Chung HJ; Hong ST Molecules; 2017 Oct; 22(10):. PubMed ID: 29064399 [TBL] [Abstract][Full Text] [Related]
49. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial. Salas-Salvadó J; Díaz-López A; Ruiz-Canela M; Basora J; Fitó M; Corella D; Serra-Majem L; Wärnberg J; Romaguera D; Estruch R; Vidal J; Martínez JA; Arós F; Vázquez C; Ros E; Vioque J; López-Miranda J; Bueno-Cavanillas A; Tur JA; Tinahones FJ; Martín V; Lapetra J; Pintó X; Daimiel L; Delgado-Rodríguez M; Matía P; Gómez-Gracia E; Díez-Espino J; Babio N; Castañer O; Sorlí JV; Fiol M; Zulet MÁ; Bulló M; Goday A; Martínez-González MÁ; Diabetes Care; 2019 May; 42(5):777-788. PubMed ID: 30389673 [TBL] [Abstract][Full Text] [Related]
50. Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target. Hoenig MR Vasc Health Risk Manag; 2008; 4(1):143-56. PubMed ID: 18629364 [TBL] [Abstract][Full Text] [Related]
51. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome. Gaillard T; Schuster D; Osei K Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282 [TBL] [Abstract][Full Text] [Related]
52. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes. Després JP Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S53-61. PubMed ID: 14502101 [TBL] [Abstract][Full Text] [Related]
53. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Babio N; Bulló M; Basora J; Martínez-González MA; Fernández-Ballart J; Márquez-Sandoval F; Molina C; Salas-Salvadó J; Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):563-70. PubMed ID: 19176282 [TBL] [Abstract][Full Text] [Related]
54. Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes. Lee HM; Zhao Y; Liu MA; Yanez D; Carnethon M; Graham Barr R; Wong ND Clin Cardiol; 2018 Jul; 41(7):959-965. PubMed ID: 29797803 [TBL] [Abstract][Full Text] [Related]
55. Cross-sectional assessment of nut consumption and obesity, metabolic syndrome and other cardiometabolic risk factors: the PREDIMED study. Ibarrola-Jurado N; Bulló M; Guasch-Ferré M; Ros E; Martínez-González MA; Corella D; Fiol M; Wärnberg J; Estruch R; Román P; Arós F; Vinyoles E; Serra-Majem L; Pintó X; Covas MI; Basora J; Salas-Salvadó J; PLoS One; 2013; 8(2):e57367. PubMed ID: 23460844 [TBL] [Abstract][Full Text] [Related]
56. Mouse models of the metabolic syndrome. Kennedy AJ; Ellacott KL; King VL; Hasty AH Dis Model Mech; 2010; 3(3-4):156-66. PubMed ID: 20212084 [TBL] [Abstract][Full Text] [Related]
57. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome. Ferdinand KC J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832 [TBL] [Abstract][Full Text] [Related]